Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab

Abstract Background Although a recent randomized clinical trial has demonstrated that the objective response rate to nivolumab for metastatic gastric cancer was 11.2%, there was no patients confirmed complete response. Herein, we report on a case of liver metastasis arising from early gastric cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tsutomu Namikawa, Nobuko Ishida, Sachi Tsuda, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki
Formato: Artigo
Idioma:Inglês
Publicado em: Japan Surgical Society 2018-07-01
Colecção:Surgical Case Reports
Assuntos:
Gastric cancer
Nivolumab
Complete response
Chemotherapy
Biomarker
Acesso em linha:http://link.springer.com/article/10.1186/s40792-018-0479-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados